NPI: 1043602105 · BAKERSFIELD, CA 93311 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 02/26/2015
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 02/26/2015 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 11,544 | $927K |
| 2019 | 9,345 | $822K |
| 2020 | 8,626 | $741K |
| 2021 | 8,065 | $693K |
| 2022 | 8,936 | $711K |
| 2023 | 8,356 | $1.02M |
| 2024 | 6,584 | $823K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 24,751 | 1,995 | $5.72M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 17,469 | 1,046 | $2K |
| J1756 | Injection, iron sucrose, 1 mg | 5,583 | 1,155 | $2K |
| J1270 | Injection, doxercalciferol, 1 mcg | 9,856 | 779 | $2K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 924 | 479 | $1K |
| 90674 | 28 | 27 | $772.33 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 15 | 14 | $175.03 |
| 85041 | 541 | 489 | $136.43 | |
| 83540 | 149 | 145 | $125.68 | |
| 85048 | 527 | 477 | $125.68 | |
| 83970 | 567 | 511 | $125.68 | |
| 82728 | 147 | 145 | $125.68 | |
| 83550 | 106 | 103 | $125.68 | |
| A4657 | Syringe, with or without needle, each | 793 | 637 | $125.68 |